Latest News about Mpox
Recent news which mentions Mpox
   UK Secures Additional Doses Of Bavarian Nordic Mpox Vaccine To Combat New Variant Threat
   
  
  
  September 17, 2024
  From Benzinga
 
   Moderna's Investigational Mpox Vaccine More Effective Than Current Approved Shot, Animal Study Shows
   
  
  
  September 06, 2024
  From Benzinga
 
   Mpox Vaccines: Challenges Persist as Congo Receives First Batch Of Doses Almost 2 Years After It Declared Epidemic
   
  
  
  September 06, 2024
  From Benzinga
 
   Mpox Vaccine: Emergent BioSolutions' Smallpox Vaccine Gets FDA Nod For Expanded Use For Individuals At High Risk Of Mpox Infection
   
  
  
  August 30, 2024
  From Benzinga
 
   EXCLUSIVE: Virax Biolabs Inks Distribution Pact For Mpox Diagnostic Kits In Europe And Middle East
   
  
  
  August 28, 2024
  From Benzinga
 
   WHO Seeks $135M In Funding To Fight Mpox: Outbreak 'Can Be Controlled, And Can Be Stopped'
   
  
  
  August 26, 2024
  From Benzinga
 
   Diagnostic Giants Labcorp, Roche To Ramp Up Testing Capacity Amid Global Concerns Over New Mpox Strain
   
  
  
  August 26, 2024
  From Benzinga
 
   Tonix Pharma Collaborates With World's Largest Vaccine Manufacturer For Mpox Vaccine
   
  
  
  August 26, 2024
  From Benzinga
 
   Why Is Diagnostic Tests Provider Applied DNA Sciences Stock Trading Higher On Friday?
   
  
  
  August 23, 2024
  From Benzinga
 
   Virax Biolabs Announces Stock Offering: What To Know
   
  
  
  August 22, 2024
  From Benzinga
 
   Snowflake, GeoVax, Zoom, Target, Tesla: Why These 5 Stocks Are On Investors' Radars Today
   
  
  
  August 21, 2024
  From Benzinga
 
   GeoVax Labs Stock Surges Ahead Of The Close, Shares Remain Volatile: What's Happening?
   
  
  
  August 21, 2024
  From Benzinga
 
   GeoVax Stock Is Tumbling Tuesday: What's Going On?
   
  
  
  August 20, 2024
  From Benzinga
 
   Virax Biolabs Shares Climb With Mpox Cases: What To Know
   
  
  
  August 19, 2024
  From Benzinga
 
   Mpox Vaccine Maker Bavarian Nordic Targets Broader Access With European Submission For Imvanex Adolescent Use During WHO Emergency
   
  
  
  August 16, 2024
  From Benzinga
 
   Mpox Declared A Global Public Health Emergency By WHO Amid Rapid International Spread
   
  August 14, 2024
  Tickers 
   NEWS
  
  
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.